Methods of determining relative potency of glatiramer acetate and use thereof in preparing a batch of glatiramer acetate as acceptable for pharmaceutical use
US2011150820A1
Methods for covalently attaching a polymer to a methionine residue in proteins and peptides
WO2006120667A2
Expression constructs and methods of using same for expressing heparanase in plants
US2008039456A1
Rigidified compounds for modulating heparanase activity
WO2006035445A2
Methods of treating pathologies associated with oxidative stress
CA2555313A1
Heparanase inhibitors and uses thereof
WO2005016227A2
Methods and pharmaceutical compositions for modulating heparanase activation and uses thereof
AU2004201462A1
Antibodies Recognising At Least One Epitope of Heparanase
US2005158822A1
High level expression of recombinant human erythropoietin having a modified 5′-UTR
AU2003242497A1
Method and Pharmaceutical Composition Utilising Heparanase
AU2002311620A1
Methods of making and using expression constructs for the expression of recombinant proteins
IL146527A
Polynucleotides and polypeptides encoded thereby distantly homologous to heparanase
AU6999701A
Polynucleotide encoding a polypeptide having heparanase activity and expression of same in transduced cells
US6699672B1
Heparanase specific molecular probes and their use research and medical applications
US7101706B1
Polynucleotides and polypeptides encoded thereby distantly homologous to heparanase
